An advisory panel for the Food and Drug Administration determined on Thursday it would recommend the agency authorize Moderna's COVID-19 vaccine, saying the benefits outweighed the risks associated with the highly-effective vaccine candidate.
The recommendation is a major step in getting a second vaccine approved for emergency use, following the FDA's authorization of the Pfizer/BioNTech vaccine last week. The FDA reportedly plans to authorize Moderna's vaccine on Friday, which would allow 5.9 million doses to begin shipment to 3,285 locations around the United States. Moderna's vaccine makes for simpler distribution than Pfizer's because it does not require ultra-cold storage conditions. The smaller batches can be stored in regular freezers, making it more accessible to hospitals in less-populated areas.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
-
Mortgages: The future of Fannie and FreddieFeature Donald Trump wants to privatize two major mortgage companies, which could make mortgages more expensive
-
Economists fear US inflation data less reliablespeed read The Labor Department is collecting less data for its consumer price index due to staffing shortages
-
Trump may team with a tech company to create a database of AmericansIn the Spotlight A recent report indicated that Trump is partnering with the tech company Palantir
-
RFK Jr. scraps Covid shots for pregnant women, kidsSpeed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sickspeed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last yearspeed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
-
Trump seeks to cut drug prices via executive orderspeed read The president's order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by the courts
-
RFK Jr. visits Texas as 2nd child dies from measlesSpeed Read An outbreak of the vaccine-preventable disease continues to grow following a decade of no recorded US measles deaths
-
Shingles vaccine cuts dementia risk, study findsSpeed Read Getting vaccinated appears to significantly reduce the chances of developing Alzheimer's and other forms of dementia
-
Measles outbreak spreads, as does RFK Jr.'s influenceSpeed Read The outbreak centered in Texas has grown to at least three states and Health Secretary Robert F. Kennedy Jr. is promoting unproven treatments
-
RFK Jr. offers alternative remedies as measles spreadsSpeed Read Health secretary Robert F. Kennedy Jr. makes unsupported claims about containing the spread as vaccine skepticism grows
